Join the club for FREE to access the whole archive and other member benefits.

Yuri Deigin

Co-founder and Director at YouthBio Therapeutics

Yuri is a biotech entrepreneur with a focus on early-stage translation of scientific breakthroughs into therapies. He has over a decade of drug discovery and development experience, and a track record of outlicensing products to Big Pharma.

Yuri has previously led several early-stage pharmaceutical startups, including one developing an Alzheimer's Disease therapeutic, and another startup developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease.

Additionally, Yuri has been a vocal evangelist of epigenetic rejuvenation by partial reprogramming with Yamanaka factors since 2017.

Visit website: https://youthbiotx.com/#yuri

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company YouthBio Therapeutics - Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors

Yuri Deigin is also referenced in the following:

Video

Live Longer World podcast #17 with Yuri Deigin as a guest

Yuri Deigin News

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

CISION PR Newswire - 14-Apr-2022

Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line

Read more...